Before cells can divide, they first need to replicate all of their chromosomes, so that each of the daughter cells can ...

Triple negative breast cancer (TNBC) is one of the most aggressive and hardest forms of breast cancer to treat, but a new study led by Weill Cornell Medicine suggests a surprising way to stop it from ...

A Weill Cornell Medicine team has found that triple-negative breast cancer depends on the enzyme EZH2 to spread. By silencing ...

Triple negative breast cancer (TNBC) is one of the most aggressive and hardest forms of breast cancer to treat, but a new study led by Weill Cornell Medicine suggests a surprising way to stop it from ...

Google DeepMind and Yale University have created an AI model called C2S-Scale 27B that helped scientists identify cancer ...

Rather than working on the surface of cells like some cancer medicines, small molecules are able to slip inside the cell to ...

Researchers have discovered that an enzyme called EZH2 drives TNBC cells to divide abnormally, which enables them to relocate ...

For 40 years, the United States has recognized October as National Breast Cancer Awareness Month. The month aims to promote ...

Innovative advancements in cell therapy enhance NK cells for solid tumors, aiming for effective treatments while prioritizing ...

T-DXd significantly improved IDFS and reduced the risk of invasive disease or death by 53% compared to T-DM1 in high-risk, HER2-positive breast cancer patients. The trial demonstrated superior ...

"Our recent research has found that Rooibos extract may counter the effects of estrogen in breast cancer cells. “Estrogen is ...